BioLineRx Ltd. Depreciation Expense
BioLineRx Ltd. (BLRX) reported Depreciation Expense of $28.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2026-03-23
| Period end | Depreciation Expense 12 month |
|---|---|
| 2025-12-31 | $28.00K 20-F · filed 2026-03-23 |
| 2024-12-31 | $10.00K 20-F · filed 2026-03-23 |
| 2023-12-31 | $37.00K 20-F · filed 2026-03-23 |
| 2022-12-31 | $39.00K 20-F · filed 2025-03-31 |
| 2021-12-31 | $42.00K 20-F · filed 2024-03-26 |
| 2020-12-31 | $70.00K 20-F · filed 2023-03-22 |
| 2019-12-31 | $78.00K 20-F · filed 2022-03-16 |
| 2018-12-31 | $27.00K 20-F · filed 2021-02-23 |
| 2017-12-31 | $29.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | $30.00K 20-F · filed 2019-03-28 |
| 2015-12-31 | $27.00K 20-F · filed 2018-03-06 |